SECURITIES AND EXCHANGE COMMISSION |
WASHINGTON, DC 20549 |
FORM 8-K |
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
April 24, 2003 |
Date of Report (Date of earliest event reported) |
HUMAN GENOME SCIENCES, INC. |
(Exact Name of Registrant as Specified in Charter) |
Delaware | 0-022962 | 22-3178468 | |||
(State or Other Jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) | |||
Incorporation) |
9410 Key West Avenue, Rockville, Maryland 20850-3338 (Address of Principal Executive Offices) (ZIP Code) |
Registrant's telephone number, including area code:(301) 309-8504 |
(Former Name or Former Address, if Changed Since Last Report) |
Item 9. | Regulation FD Disclosure (Item 12, Disclosure of Results of Operations and Financial Condition). |
The following information is furnished pursuant to Item 12, "Disclosure of Results of Operations and Financial Condition": |
On April 24, 2003, Human Genome Sciences, Inc. issued a press release reporting its financial results for the three months ended March 31, 2003. The press release is attached hereto as Exhibit 99.1. |
Item 7. | Financial Statements and Exhibits. |
(c) Exhibits |
Exhibit | Description | |||
99.1 | Press Release issued April 24, 2003 |
SIGNATURES |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
HUMAN GENOME SCIENCES, INC. | |||
Date: April 24, 2003 | By: | /s/ Steven C. Mayer Steven C. Mayer Senior Vice President and Chief Financial Officer |